The gut-brain axis, that is, the bidirectional communication system between the gut and the brain, has gained central importance in PD research over the past 20 years
Beyond improving glycemic control, these medications help with weight loss, quiet food noise and T1D hunger, and reduce the risk of heart and kidney disease
As a result, Foundayo will enter the market roughly three months after Novo Nordisks Wegovy pill, intensifying competition between the two companies in the evolving GLP-1 space.
This could indicate medication side effects, dehydration, or underlying issues such as urinary tract infections or diabetes management complications
Hims retort
The matter of the issue (e.g